Trinity News Daily - U.S. and World Latest News from Technology, Entertainment, Health and Sports

Breaking Daily News and Current Events

Saturday, January 23, 2021
Log in
  • Headlines
  • Entertainment
  • Health
  • Sports
  • Technology
  • U.S.
  • World
  • Latest News
    • Larry David Decided the Return of ‘Curb Your Enthusiasm’ with New Season
    • Spiders Start to Fly in Chicago, As Their Season Begins
    • Hummingbird Vision Is Adapted To High-Speed Flight
    • Kronos Is The Latest Nickname For 2 Planet Eating Stars
    • The Ecosystem of Teller Lake in Colorado Threatened by Thousands of Goldfish
    • Researchers Dream of a World Without Mosquitoes
    • NASA Shares Spectacular Pic of Earthrise over Moon
    • The Ozone Layer is Repairing Itself
    • Giraffes Are In Danger Of Becoming Extinct In The Wild
    • Pregnant Woman Stabbed And Her Unborn Child Removed From Her Belly

Pages

  • Privacy Policy GDPR
  • Terms and Conditions
  • Trinity News Daily Staff
  • Who We Are

Recent Posts

  • Documentary Tells Story of Three Identical Strangers June 29, 2018
  • First Look at DiCaprio and Pitt in “Once Upon a Time in Hollywood” June 28, 2018
  • Jared Leto to Star in Spider-Man Spinoff “Morbius” June 28, 2018
  • Toby Kebbell Joins Vin Diesel’s Bloodshot June 27, 2018
  • New Record-Breaking Number of Academy Members Announced June 26, 2018
  • Actress Heather Locklear Arrested Once Again June 26, 2018
  • Game of Thrones’ Rose Leslie and Kit Harington Got Married June 25, 2018

The First Biosimilar Drug Has Been Approved By The FDA

By Leave a Comment

Email, RSS Follow

The First Biosimilar Drug Has Been Approved By The FDA

Novartis’ white blood cell-boosting Zarxio the first biosimilar drug has been approved by the FDA (The Food and Drug Administration). On Friday, March 6, U.S. regulators approved the sale of the first ever biotechnology drug.

Zarxio contains the same active compound as Neupogen, developed by Amgen Inc. which in 2014 brought the company a profit of $1.2 billion from its sales. This new drug was developed by Novartis’ Sandoz generic unit.

FDA said this new drug met the five conditions necessary for sale approval. These are the same conditions Neupogen had to accomplish. Zarxio will be used to help cancer patients under various treatments avoid infections.

In Europe, biosimilar drugs have been available for patients since 2006. In the United States, however, it wasn’t until 2010 when the Affordable Care Act, or Obamacare, came into effect that the FDA gained authority to approve biosimilars.

Health insurance agencies consider that biotech medicine with expired patents will also be confronted with lower-cost competitors in the U.S. This will lead to some reductions in costs, the same way generic forms of conventional drugs have reduced the cost of prescriptions.

Biological drugs can cost a patient even tens of thousands of dollars per year, representing 30 percent of the sum spent by the U.S. on medication.

In comparison to chemical compounds like aspirin or statins, biotech medicine is generated within living cells so small variations do occur, depending on the production method. This means, “a copycat version can only ever be similar to the original, rather than identical”.

There is one issue still unsolved when it comes to biotech drugs and that is its official generic name, an important aspect for pharmacists when carrying out prescriptions. The FDA stated that, for the time being, the name will be “filgrastim-sndz”. It will remain this way until the company establishes a complete naming policy.

It is expected that the wholesale price for the smallest packaged daily dose will be $315 but Sandoz did not give any information regarding Zarxio’s official price. Carol Lynch, global head of biopharmaceuticals and oncology injectables said that it will be “competitively priced”.

The competitor, Amgen will file a lawsuit in an attempt to block the release of Zarxio. Sandoz had initially agreed to postpone the launch until the court decides whether Amgen’s request will be accepted or not but is now planning on releasing the drug until April 10.

Image Source: Cancer Therapy Advisor

Email, RSS Follow

Filed Under: Health Tagged With: FDA approves Novartis' white blood cell-boosting Zarxio, first biosimilar drug Zarxio approved by FDA, presumably smallest packaged daily dose for Zarxio will be $315

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 8 other subscribers

Recent Articles

cannabis plants

Prototype App Could Tell the Actual Effects of Cannabis on a Person

By Leave a Comment

Viagra pill

Viagra Might Help Fight Cancer (Study)

By Leave a Comment

Opioids in a plastic container.

Opioids Just As Effective As Over The Counter Drugs For Treating Chronic Pain (Study)

By Leave a Comment

Child being exposed to bright lights from a tablet.

Bright Lights Before Bedtime Can Prevent Kids From Going To Sleep (Study)

By Leave a Comment

Several opioid pills laid on a black surface.

The Opioid Pandemic Affects More and More US Children (Study)

By Leave a Comment

Close-up of a colon cancer cell.

Eating Nuts May Help Avoid Colon Cancer (Study)

By Leave a Comment

Woman suffering from obesity.

Prolonged Obesity Increases Risk Of Heart Disease (Study)

By Leave a Comment

Glass of red wine.

Drinking Red Wine May Keep Teeth And Gums Healthy (Study)

By Leave a Comment

Single fathers have higher mortality risk.

Mortality Rate For Single Fathers Is Surprisingly High (Study)

By Leave a Comment

Woman with her male partner on a field.

Your Partner Can Cheat On You Even If They’re Sexually Satisfied (Study)

By Leave a Comment

Cloth embroidered by a person suffering from schizophrenia.

Schizophrenia Patients Can Manage Verbal Hallucinations By Playing A Video Game

By Leave a Comment

mouse on leaf in tree

Researchers are Testing a Cancer Vaccine for Human Usage (Study)

By Leave a Comment

white pills on white surface

FDA Changes Packaging of Anti-Diarrhea Drug to Avoid Abuse

By Leave a Comment

Drinking too much alcohol during your teen years was potentially linked to liver diseases later on.

Liver Diseases Likelier In People Who Drank Large Amounts Of Alcohol In Their Adolescence

By Leave a Comment

Related Articles

  • cannabis plants

    Prototype App Could Tell the Actual Effects of Cannabis on a Person

  • Viagra pill

    Viagra Might Help Fight Cancer (Study)

  • Opioids in a plastic container.

    Opioids Just As Effective As Over The Counter Drugs For Treating Chronic Pain (Study)

  • Child being exposed to bright lights from a tablet.

    Bright Lights Before Bedtime Can Prevent Kids From Going To Sleep (Study)

  • Several opioid pills laid on a black surface.

    The Opioid Pandemic Affects More and More US Children (Study)

  • Close-up of a colon cancer cell.

    Eating Nuts May Help Avoid Colon Cancer (Study)

  • Woman suffering from obesity.

    Prolonged Obesity Increases Risk Of Heart Disease (Study)

  • Glass of red wine.

    Drinking Red Wine May Keep Teeth And Gums Healthy (Study)

  • Single fathers have higher mortality risk.

    Mortality Rate For Single Fathers Is Surprisingly High (Study)

  • Woman with her male partner on a field.

    Your Partner Can Cheat On You Even If They’re Sexually Satisfied (Study)

Categories

  • Business
  • Entertainment
  • Headlines
  • Health
  • Nature
  • Science
  • Sports
  • Technology
  • U.S.
  • Uncategorized
  • World

Copyright © 2021 TrinityNewsDaily.com

About · Staff · Terms and Conditions · Privacy Policy

This website uses cookies to ensure you get the best experience on our website. Learn more.